Vertex Pharmaceuticals Incorporated (VRTX) is listed on NASDAQ in Pharmaceutical Stocks. It is $541.72, -1.06%, with a $137.3B market cap. RSI is 61.7, near overbought. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 61.7 Near Overbought
Market Cap $137.3B
Volume 500.9K
Fundamentals — 10-Q Q2 2026
Revenue $6.3B
Net Income $2.1B
EPS $8.33
Gross Margin 86.0%
Operating Margin 37.7%
Net Margin 33.7%
P/E Ratio 65.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 1,500 | $524.99 | $787,485 | 2026 Jul 2 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 1,541 | $519.00 | $799,779 | 2026 Jul 2 |
| Liu Joy | EVP and Chief Legal Officer | Sell | 828 | $502.71 | $416,244 | 2026 Jul 1 |
| Bozic Carmen | EVP and CMO | Sell | 596 | $482.50 | $287,570 | 2026 Jun 26 |
| Bozic Carmen | EVP and CMO | Sell | 1,020 | $462.17 | $471,413 | 2026 Jun 18 |
| Bozic Carmen | EVP and CMO | Sell | 4,062 | $450.00 | $1.8M | 2026 Jun 15 |
| Bozic Carmen | EVP and CMO | Sell | 1,745 | $450.00 | $785,250 | 2026 Jun 5 |
| Liu Joy | EVP and Chief Legal Officer | Sell | 828 | $439.91 | $364,245 | 2026 Jun 1 |
| Bozic Carmen | EVP and CMO | Sell | 1,974 | $450.00 | $888,300 | 2026 May 29 |
| Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 33 | $453.45 | $14,964 | 2026 May 15 |
| Bozic Carmen | EVP and CMO | Sell | 1,354 | $453.45 | $613,971 | 2026 May 15 |
| Bozic Carmen | EVP and CMO | Sell | 6,988 | $450.00 | $3.1M | 2026 May 12 |
| Bhatia Sangeeta N. | Director | Sell | 318 | $423.73 | $134,746 | 2026 May 4 |
| Liu Joy | EVP and Chief Legal Officer | Sell | 1,104 | $425.02 | $469,222 | 2026 May 1 |
| Liu Joy | EVP and Chief Legal Officer | Sell | 978 | $449.17 | $439,288 | 2026 Apr 1 |
| Bozic Carmen | EVP and CMO | Sell | 2,329 | $450.95 | $1.1M | 2026 Mar 27 |
| Bozic Carmen | EVP and CMO | Sell | 2,329 | $481.79 | $1.1M | 2026 Mar 13 |
| McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2,633 | $498.42 | $1.3M | 2026 Mar 11 |
| Liu Joy | EVP and Chief Legal Officer | Sell | 892 | $495.96 | $442,396 | 2026 Mar 2 |
| Bozic Carmen | EVP and CMO | Sell | 2,329 | $480.31 | $1.1M | 2026 Feb 27 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $162.66 | 48.4 | -- |
| | $45.60 | 41.8 | -- |
| | $794.08 | 58.2 | $82.1B |
| | $66.58 | 60.7 | $136.0B |
Take VRTX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put VRTX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Vertex Pharmaceuticals Incorporated next reports.
Set alerts on VRTX
Get notified when Vertex Pharmaceuticals Incorporated hits your price targets or technical conditions are met.
Get Started Free